Decera Clinical Education Infectious Disease Podcast

In this episode, Roger Bedimo, MD, MS, FACP, and Eric S. Daar, MD, discuss caring for heavily treatment–experienced patients with HIV, including assessment of virologic failure and current treatment options for patients with multiclass drug resistance. Presenters: Roger Bedimo, MD, MS, FACP  Professor of Medicine Division of Infectious Diseases  University of Texas Southwestern Medical Center  Sec...

In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19.  Presenter: Jens D...

In this episode, the second in a 3-part series on Ending the HIV Epidemic, Jason Halperin, MD, MPH, and Aadia I. Rana, MD, discuss treatment as prevention, the critical infrastructure needed to implement rapid ART, the importance of routinely assessing for barriers to care, and real-time monitoring strategies that improve patient adherence and engagement. Following their dialogue, the faculty fiel...

In this episode, Dr. Terrault discusses results from key viral hepatitis studies reported at the American Association for the Study of  Liver Diseases (AASLD) 2020 annual conference, The Liver Meeting Digital Experience, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations. Presenter: Norah Terrault, M...

In this episode, Brian Wood, MD, discusses HIV treatment safety and tolerability data from 2020 conferences and addresses how he manages ARV-associated weight gain his patients and how the latest data on ART safety during conception and pregnancy impact his treatment recommendations. Presenters: Brian Wood, MD Associate Professor of Medicine Division of Allergy and Infectious Diseases University o...

In this episode, Part 2 of an 4-part series, Dr. Jonathan Appelbaum, Dr. Howard Grossman, and Professor Jürgen Rockstroh discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities. Presenters: Jonathan Appelbaum MD, FACP, AAHIVS Laurie L. Dozier Jr, M...

In this episode, Dr. Joseph Eron and Dr. Jason Halperin discuss caring for complex HIV cases, including patients with underlying resistance or comorbidities. Presenters: Joseph J. Eron, Jr., MD Professor of Medicine and Epidemiology University of North Carolina School of Medicine Director , AIDS Clinical Trials Unit University of North Carolina Chapel Hill, North Carolina Jason Halperin, MD, MPH A...

In this episode, Part 12 of an ongoing series, David Heymann, BA, MD, DTM&H, provides a brief update on strategies for moving forward and living safely within the continued COVID-19 pandemic. After the update, Professor Heymann answers clinician questions on various aspects of COVID-19.  Presenter: David Heymann, BA, MD, DTM&H  Professor of Infectious Disease Epidemiology London School of Hygiene...

In this episode, the first in a 3-part series on Ending the HIV Epidemic, Lisa K. Fitzpatrick, MD, MPH, MPA, and David Malebranche, MD, MPH, discuss strategies to expand early HIV testing, maximize patient engagement in HIV care, navigate emerging clusters of HIV infection, and combat HIV-related stigma. Following their dialogue, the faculty field clinician questions on HIV diagnosis and managemen...

In this episode, Dr. Gandhi discusses results from key studies reported at the virtual IDWeek 2020 conference, including new findings on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the pandemic, and treatment and prevention strategies. Presenter: Rajesh T. Gandhi, MD  Professor of Medicine   Department of Infectious Dise...

In this episode, Part 11 of an ongoing series, Sharon R. Lewin AO, FRACP, PhD, FAHMS, provides a brief update on the role of interferons in COVID-19. After the update, Dr. Lewin answers clinician questions on various aspects of COVID-19.  Presenter: Sharon R. Lewin AO, FRACP, PhD, FAHMS Director ,  The Peter Doherty Institute for Infection and Immunity Melbourne Laureate Professor of Infectious Di...

In this episode, Dr. Sherer discusses results from key studies reported at the 2020 International Congress on Drug Therapy in HIV Infection ( HIV Glasgow 2020 Virtual) , including studies on long-term 2-drug and 3-drug antiretroviral therapy, newer 3-drug regimens in patients with baseline NRTI resistance, investigational HIV treatment approaches, and important comoribidities in patients with HIV,...

In this episode, Part 10 of an ongoing series, Wong Chen Seong, MBBS, MRCP(UK), FAMS, provides a brief update on COVID-19 and HIV. After the update, Dr. Wong answers clinician questions on various aspects of COVID-19. Presenter: Wong Chen Seong, MBBS, MRCP(UK), FAMS Head , NCID Clinical HIV Programme Deputy Director , National HIV Programme National Centre for Infectious Diseases  Consultant Depar...

In this episode, Dr. Rath discusses results from key studies reported at the European Society of Clinical Microbiology and Infectious Diseases Conference on Corona Virus Disease (ECCVID), including studies on COVID-19 screening and diagnostics, vaccines, prevention strategies, social disparities, and therapeutics. Presenter: Barbara Rath, MD, PhD, HDR  Co-founder & Chair   The Vienna Vaccine Safet...

In this episode, Part 9 of an ongoing series, Lynora Saxinger, MD, FRCPC, CTropMed, provides a brief update on key concepts in COVID-19 immunity and the latest information on treatment strategies. After the update, Dr. Saxinger answers clinician questions on various aspects of COVID-19.  Presenter: Lynora Saxinger, MD, FRCPC, CTropMed Cochair , Scientific Advisory Group Alberta COVID-19 Emergency...

In this episode, Part 8 of an ongoing series, Paul E. Sax, MD, provides a brief update on current treatment options for COVID-19. After the update, Dr. Sax answers clinician questions on various aspects of COVID-19. Presenter: Paul E. Sax, MD Clinical Director  HIV Program and Division of Infectious Diseases Brigham and Women's Hospital Professor of Medicine Harvard Medical School Boston, Massachu...

In this episode, W. David Hardy, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV. Presenter: W. David Hardy, MD Scientific and Medical Consultant Adjunct Professor of Medicine Division of Infectious Diseases  Johns Hopkins University School of Medicine Baltimore, Maryland Content based on an online CME program suppor...

In this episode, Part 7 of an ongoing 12-part COVID-19 series, Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS, provides a brief update on COVID-19 risk and prevention strategies among healthcare workers. After the update, Professor Leo answers clinician questions on various aspects of COVID-19.  Presenter: Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Professor Lee Kong Chian School of Medicine Saw Swee Hock...

In this episode, Part 6 of an ongoing 12-part COVID-19 series, Jens D. Lundgren, MD, DMSc, provides a brief update on vaccine development and treatment strategies. After the update, Dr. Lundgren answers clinician questions on various aspects of COVID-19.  Note that this podcast was recorded on August 4, 2020. Some information may have changed since that time. Presenter: Jens D. Lundgren, MD, DMSc...

In this episode, Part 1 of an 4-part series, Dr. Joseph J. Eron, Jr., Professor Chloe Orkin, and Dr. Paul E. Sax, discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities. Presenters: Joseph J. Eron, Jr., MD Professor of Medicine and Epidemiology Un...

In this episode, Dr. Stefan Zeuzem discusses results from key viral hepatitis studies reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver, including important findings from the following reports: Update on global progress toward HCV elimination goals SToP-C: HCV treatment-as-prevention in Australian prisons SHARED cohort: corr...

In this episode, Part 5 of an ongoing 12-part COVID-19 series, David Heymann, BA, MD, DTM&H, provides a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission,. After the update, Professor Heymann answers critical clinician questions on COVID-19 transmission and mitigation. Presenter: David Heymann, BA, MD, DTM&H Professor,  Infectious Disease Epi...

In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clin...

In this episode, Dr. Orkin discusses results from key studies reported at AIDS 2020: Virtual, with new data on the following hot topics: current ART in principal populations, including older patients and women who become pregnant; metabolic outcomes during ART; HIV and COVID-19; investigational ART strategies; and HIV prevention. The overview includes:  The ADVANCE trial comparing initial ART with...

In this episode, Part 4 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends and a concise summary of updates to the US National Institutes of Health and the Infectious Diseases Society of America recommendations for managing COVID-19. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, dia...